Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
RC
|
Adam Zausmer
Chief Credit Officer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 3.21% |
$54,200
$5.42 p/Share
|
Mar 07
2025 |
GMGI
|
Aleksandar Milovanovic |
BUY
Open market or private purchase
|
Direct | 50,000 Added 0.06% |
$108,000
$2.16 p/Share
|
Mar 07
2025 |
GDRZF
|
Camac Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100 Added 0.0% |
$170
$1.7 p/Share
|
Mar 07
2025 |
J
|
Manuel J Fernandez |
BUY
Open market or private purchase
|
Direct | 70 Added 0.73% |
$8,596
$122.8 p/Share
|
Mar 07
2025 |
NMFC
|
David Ogens
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 2.51% |
$56,500
$11.3 p/Share
|
Mar 07
2025 |
CE
|
Mark Christopher Murray
SVP - Acetyls |
BUY
Open market or private purchase
|
Direct | 2,353 Added 14.4% |
$128,120
$54.45 p/Share
|
Mar 07
2025 |
CE
|
Scott Mc Dougald Sutton
Director |
BUY
Open market or private purchase
|
Direct | 7,450 Added 33.18% |
$407,142
$54.65 p/Share
|
Mar 07
2025 |
CE
|
Deborah J. Kissire
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 31.11% |
$54,280
$54.28 p/Share
|
Mar 07
2025 |
MIRM
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect | 580 Added 0.0% |
$25,061
$43.21 p/Share
|
Mar 07
2025 |
CE
|
Ganesh Moorthy
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.0% |
$54,670
$54.67 p/Share
|
Mar 07
2025 |
LKFN
|
M Scott Welch
Director |
BUY
Open market or private purchase
|
Indirect | 604 Added 0.0% |
$37,538
$62.15 p/Share
|
Mar 07
2025 |
MPLN
|
Douglas Michael Garis
EVP&CFO |
BUY
Open market or private purchase
|
Indirect | 8,919 Added 0.0% |
$182,839
$20.5 p/Share
|
Mar 07
2025 |
MPLN
|
Travis Dalton
Pres., CEO & Executive Chair |
BUY
Open market or private purchase
|
Direct | 5,252 Added 2.15% |
$100,838
$19.2 p/Share
|
Mar 07
2025 |
RLJ
|
Patricia L Gibson
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 8.05% |
$93,800
$9.38 p/Share
|
Mar 07
2025 |
RDVT
|
Lisa M. Stanton |
BUY
Open market or private purchase
|
Direct | 1,000 Added 3.6% |
$36,120
$36.12 p/Share
|
Mar 07
2025 |
SUNS
|
Alexander C Frank
Director |
BUY
Open market or private purchase
|
Direct | 4,400 Added 32.5% |
$49,720
$11.3 p/Share
|
Mar 07
2025 |
AWRE
|
Ajay K Amlani
President & CEO |
BUY
Open market or private purchase
|
Direct | 28,950 Added 10.99% |
$43,425
$1.5 p/Share
|
Mar 07
2025 |
VRME
|
Adam H Stedham
CEO and President |
BUY
Open market or private purchase
|
Direct | 45,000 Added 12.42% |
$31,950
$0.71 p/Share
|
Mar 07
2025 |
CZR
|
Don R Kornstein
Director |
BUY
Open market or private purchase
|
Direct | 4,000 Added 6.64% |
$108,000
$27.0 p/Share
|
Mar 07
2025 |
SEPN
|
Alan Ezekowitz |
BUY
Open market or private purchase
|
Direct | 13,319 Added 10.19% |
$92,300
$6.93 p/Share
|
Mar 07
2025 |
BOWL
|
Robert M. Lavan
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 161 Added 0.2% |
$1,510
$9.38 p/Share
|
Mar 07
2025 |
BOWL
|
John Alan Young
Director |
BUY
Open market or private purchase
|
Direct | 100 Added 0.14% |
$894
$8.95 p/Share
|
Mar 07
2025 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.04% |
$3,951
$1317.2 p/Share
|
Mar 07
2025 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 7 Added 0.0% |
$9,263
$1323.36 p/Share
|
Mar 07
2025 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 918 Added 0.0% |
$2,359
$2.57 p/Share
|
Mar 07
2025 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 356 Added 0.56% |
$914
$2.57 p/Share
|
Mar 07
2025 |
CZNC
|
Katherine W Shattuck |
BUY
Open market or private purchase
|
Direct | 107 Added 1.36% |
$2,156
$20.15 p/Share
|
Mar 07
2025 |
CZNC
|
Frank G Pellegrino |
BUY
Open market or private purchase
|
Direct | 232 Added 0.55% |
$4,674
$20.15 p/Share
|
Mar 07
2025 |
ENX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 9,500 Added 0.0% |
$93,004
$9.79 p/Share
|
Mar 07
2025 |
STXS
|
Paul J Isaac
Director |
BUY
Open market or private purchase
|
Indirect | 1,489 Added 0.0% |
$2,665
$1.79 p/Share
|
Mar 07
2025 |
GRX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,685 Added 0.0% |
$27,199
$10.13 p/Share
|
Mar 07
2025 |
NOG
|
Nicholas L. O'Grady
CEO |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.44% |
$27,480
$27.48 p/Share
|
Mar 07
2025 |
Ctth
|
Ctt Pharmaceutical Holdings, Inc.
CEO |
BUY
Open market or private purchase
|
Direct | 11,950 Added 0.18% |
$1,075
$0.09 p/Share
|
Mar 07
2025 |
BHRB
|
Julian Forrest Barnwell Jr.
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.0% |
$59,750
$59.75 p/Share
|
Mar 07
2025 |
STRC
|
Benjamin G Wolff
PRESIDENT & CEO |
BUY
Open market or private purchase
|
Direct | 5,000 Added 0.38% |
$32,000
$6.4 p/Share
|
Mar 07
2025 |
NTST
|
Mark Manheimer
President, CEO and Secretary |
BUY
Open market or private purchase
|
Direct | 3,616 Added 1.21% |
$55,071
$15.23 p/Share
|
Mar 07
2025 |
EVH
|
Richard M Jelinek
Director |
BUY
Open market or private purchase
|
Indirect | 30,000 Added 0.0% |
$273,900
$9.13 p/Share
|
Mar 07
2025 |
EVH
|
Brendan B Springstubb
Director |
BUY
Open market or private purchase
|
Direct | 15,000 Added 35.85% |
$139,050
$9.27 p/Share
|
Mar 07
2025 |
CDXC
|
Carlos Luis Lopez
SVP, General Counsel |
BUY
Open market or private purchase
|
Direct | 273 Added 10.82% |
$2,145
$7.86 p/Share
|
Mar 07
2025 |
EVH
|
Kim Keck
Director |
BUY
Open market or private purchase
|
Direct | 10,540 Added 21.05% |
$99,497
$9.44 p/Share
|
Mar 07
2025 |
IHRT
|
Richard J Bressler |
BUY
Open market or private purchase
|
Direct | 100,000 Added 2.69% |
$179,000
$1.79 p/Share
|
Mar 07
2025 |
FA
|
Steven Irwin Marks
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 4.72% |
$13,500
$13.5 p/Share
|
Mar 07
2025 |
AMPY
|
Martyn Willsher |
BUY
Open market or private purchase
|
Direct | 15,000 Added 4.6% |
$57,600
$3.84 p/Share
|
Mar 07
2025 |
AMPY
|
James Frew |
BUY
Open market or private purchase
|
Direct | 15,000 Added 21.67% |
$57,750
$3.85 p/Share
|
Mar 07
2025 |
AMPY
|
Todd R Snyder |
BUY
Open market or private purchase
|
Direct | 25,000 Added 18.74% |
$95,750
$3.83 p/Share
|
Mar 07
2025 |
EGBN
|
Eric R Newell
Senior EVP, CFO |
BUY
Open market or private purchase
|
Direct | 1,170 Added 3.91% |
$25,002
$21.37 p/Share
|
Mar 07
2025 |
BE
|
Kr Sridhar
Chairman & CEO |
BUY
Open market or private sale
|
Direct | 35,645 Added 1.31% |
$819,835
$23.0 p/Share
|
Mar 07
2025 |
MRVL
|
Brad W Buss
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 3.33% |
$207,000
$69.0 p/Share
|
Mar 07
2025 |
ECAT
|
Black Rock, Inc. |
BUY
Open market or private purchase
|
Direct | 79,600 Added 25.0% |
$1,313,400
$16.5 p/Share
|
Mar 07
2025 |
JANX
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect | 110,206 Added 0.0% |
$3,418,590
$31.02 p/Share
|
Mar 07
2025 |